ClinicalTrials.Veeva

Menu

The Effect of Panax Notoginseng Powders on Rheumatic Pain

C

Chengdu PLA General Hospital

Status

Unknown

Conditions

Rheumatic Pain

Treatments

Dietary Supplement: Panax Notoginseng Powder 10g
Dietary Supplement: Panax Notoginseng Powder 5g
Dietary Supplement: Panax Notoginseng Powder 1g
Drug: Celecoxib Capsule 400 mg daily
Dietary Supplement: Panax Notoginseng Powder 15g

Study type

Interventional

Funder types

Other

Identifiers

NCT02260336
PNP01RP001

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of Panax Notoginseng Powders on Rheumatic Pain.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • had a diagnosis of classic or definite RA
  • without conflict to the written, informed consent signed prior to the enrollment.

Exclusion criteria

  • uncontrolled medical problems
  • organic brain syndrome
  • major psychiatric disturbances
  • major communicative disorders
  • a history of severe noncompliance
  • less than 7 years of formal education, or illiteracy
  • being included in other clinical trial within the last 4 weeks
  • with abnormal liver or kidney function (more than 1 time above the high normal)
  • with serious cardiovascular disease
  • with hematologic disease
  • being in pregnancy, lactation period or under a pregnancy plan
  • with severe gastrointestinal disease
  • with contraindication or being allergic to the test drugs
  • being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as non-steroidal anti-inflammatory drugs
  • being not compatible for the trial medication, or other circumstances at the discretion of investigators
  • without legal capacity or only with limited legal capacity

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

80 participants in 5 patient groups

Panax Notoginseng Powder 1g
Experimental group
Description:
Panax Notoginseng Powder 1g, daily
Treatment:
Dietary Supplement: Panax Notoginseng Powder 1g
Panax Notoginseng Powder 5g
Experimental group
Description:
Panax Notoginseng Powder 5g,daily
Treatment:
Dietary Supplement: Panax Notoginseng Powder 5g
Panax Notoginseng Powder 10g
Experimental group
Description:
Panax Notoginseng Powder 10g,daily
Treatment:
Dietary Supplement: Panax Notoginseng Powder 10g
Panax Notoginseng Powder 15g
Experimental group
Description:
Panax Notoginseng Powder 15g,daily
Treatment:
Dietary Supplement: Panax Notoginseng Powder 15g
Celecoxib Capsule 400 mg daily
Active Comparator group
Description:
Celecoxib Capsule 400 mg daily
Treatment:
Drug: Celecoxib Capsule 400 mg daily

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems